<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00885586</url>
  </required_header>
  <id_info>
    <org_study_id>AcuZoster Effectiveness 2006</org_study_id>
    <nct_id>NCT00885586</nct_id>
  </id_info>
  <brief_title>Acupuncture in Herpes Zoster Neuralgia (ACUZoster)</brief_title>
  <acronym>ACUZoster</acronym>
  <official_title>Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dominik Irnich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Symptoms that herald herpes zoster include pruritus, dysesthesia and pain along the
      distribution of the involved dermatome. The most distressing symptom is typically pain and
      the most feared complication is postherpetic neuralgia (PHN), the persistence of pain long
      after rash healing. PHN is defined as pain persisting more than 3 months after the rash has
      healed. Both, the acute pain associated with herpes zoster and the chronic pain of PHN, have
      multiple adverse effects on health-related quality of life.

      The primary objective of the trial presented is to investigate whether a 4 week
      semi-standardised acupuncture is non-inferior (first step) or superior (second step) to (a)
      the anticonvulsive drug gabapentin and (b) sham laser acupuncture in the treatment of pain
      associated with herpes zoster in addition to standardised analgesics. Secondary objectives
      include an assessment of the change of sensoric function, of long-term effectiveness, the
      occurrence of PHN and an evaluation of several pain specific questionnaires
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alteration of pain intensity after treatment</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative sensory testing</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Herpes Zoster</condition>
  <condition>Postherpetic Neuralgia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Sham-laser acupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham laser acupuncture (c) is applied at equivalent points as needle acupuncture. Laser irradiation is faked.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gabapentine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard analgesic treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acupuncture treatment is semi-standardized, i.e. beside a scheme of basic points, individual points can be chosen according to the TCM diagnostic pattern.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham-laser acupuncture</intervention_name>
    <description>Laser irradiation is faked, approaching a non-functioning laser pen.</description>
    <arm_group_label>Sham-laser acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gabapentine</intervention_name>
    <description>Patients in this arm are treated individually with gabapentine 900 mg/d - 3600 mg/d, according to the recommended scheme given by the manufacturer</description>
    <arm_group_label>gabapentine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>The needle acupuncture technique used in this trial is performed according the traditional way (TCM) using expendable needles.</description>
    <arm_group_label>Acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of acute HZ

          -  Pain intensity &gt; 30 mm visual analog scale

        Exclusion Criteria:

          -  Patients with insulin-dependent diabetes mellitus or other diseases influencing the
             peripheral sensibility (e.g., polyneuropathia, chronic pain syndromes, cutaneous
             irritations i.e. burns)

          -  Patients under age

          -  Uncompliance

          -  Pregnancy or lactation

          -  Surgery within the last 3 month

          -  Severe heart/lung/kidney disease

          -  Diseases influencing the quality of life

          -  Psychiatric diseases (e.g., depression, schizophrenia, dementia)

          -  Chronic intake of analgesics, neuroleptics, antidepressants, corticoids,
             alpha-agonists

          -  Acupuncture, transdermal electric neurostimulation or other Complementary and
             Alternative Medicine treatment within the last 4 weeks

          -  Contraindications according to the summary of product informations against analgesic
             treatment (i.e., metamizol, paracetamol, tramadol, morphine) or the investigational
             medicinal products (gabapentine, acupuncture needles)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Multidisciplinary Pain Unit, University of Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Fleckenstein J, Kramer S, Hoffrogge P, Thoma S, Lang PM, Lehmeyer L, Schober GM, Pfab F, Ring J, Weisenseel P, Schotten KJ, Mansmann U, Irnich D. Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. BMC Complement Altern Med. 2009 Aug 12;9:31. doi: 10.1186/1472-6882-9-31.</citation>
    <PMID>19674449</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2009</study_first_submitted>
  <study_first_submitted_qc>April 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2009</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Dominik Irnich</investigator_full_name>
    <investigator_title>PD Dr. Dominik Irnich</investigator_title>
  </responsible_party>
  <keyword>herpes zoster</keyword>
  <keyword>neuropathic pain</keyword>
  <keyword>acupuncture</keyword>
  <keyword>randomised controlled trial</keyword>
  <keyword>acute herpes zoster</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Herpes Zoster</mesh_term>
    <mesh_term>Neuralgia, Postherpetic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

